Biodeal Pharmaceuticals, a Himachal Pradesh, India-based contract development and manufacturing company, received an INR110 Cr Investment From Piramal Alternatives.
The company intends to use the funds to improve infrastructure and capacities, upgrading technology, and underlay a dedicated nutraceuticals manufacturing facility.
Led by Anurag Kumar, MD, Biodeal Pharmaceuticals, is an integrated pharmaceutical manufacturing and marketing organization with offerings in pharmaceuticals, cosmetics and nutraceuticals. It supplies products to customers across 36 countries through contract manufacturing services and its own brands’ presence. The company has a manufacturing facility at Nalagarh in the state of Himachal Pradesh. The facility is approved by WHO-GMP guidelines and has ISO 9001:2015 accreditation with GLP, HALAL, CE, TFDA, HACCP, Non-Convection Certificate, MSME, NCB (Narcotics control bureau), RCMC (Registration come membership certificate) Pharmexcil and FSSAI certification, International accreditation of PICS, Tanzania Medicine & Medical Devices Authority, Ministry of Health PPB Kenya, Ministry of Health Ethiopia, Ministry of Health Vietnam, Ministry of Health Yemen, Ministry of Health Iran and many more.
Biodeal has presence all across geographies with its own chain of brands, offering vitamins, multi complex, antioxidants, amino acids, omegas, herbals and varied categories to cater to specific needs.
FinSMEs
08/04/2024